FDA Approves Stelara for Adults with Moderate-to-Severe Active Crohn’s Disease

FDA Approves Stelara for Adults with Moderate-to-Severe Active Crohn’s Disease
Janssen Biotech recently announced that the company’s Stelara (ustekinumab) for the treatment of moderate-to-severe active Crohn’s disease in adults, has been approved by the U.S. Food and Drug Administration (FDA). Stelara is the first approved biologic treatment for Crohn’s that targets interleukin (IL)-12 and IL-23 cytokines — which are known to play a critical role in immune and

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *